News & Events

Rockville, MD (April 3, 2008) – BD Biosciences, a segment of BD, today announced the launch of the BD™ High-Performance Calcium Dye Assay kit ─ a next-generation kit that allows life science researchers to better analyze calcium signaling in living cells.

“BD Biosciences’ new high-performance calcium dye assay kits provide today’s researchers with a powerful tool to analyze intracellular calcium flux that can aid in vital drug discovery research,” said Xiao Li, Manager, Assay Development, BD Biosciences. “It demonstrates BD Biosciences’ commitment to providing today’s researchers a robust portfolio of instruments, reagents and assays to bolster our understanding of cellular biology.”

Since introducing the original BD Calcium Assay Kit three years ago, BD Biosciences has continuously improved the kit’s performance. Internal and customer data indicate that this new assay kit can provide greater overall performance than other commercially available homogeneous calcium assay kits.

The new BD High-Performance Calcium Dye Assay Kit works with a wide variety of cells and can be customized for large-volume users. It also includes the following key features:

• Higher signal to background for clearer results
• Homogeneous no-wash format for ease of use and improved data quality

To find out more, please visit: http://www.bdbiosciences.com/bioimaging.

About BD

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.

###